Opportunity
Simpler Grants.gov #PAR-26-150
NCI Research Grant for Early-Onset Cancer Causes and Detection
Buyer
National Institutes of Health
Posted
October 04, 2023
Respond By
October 05, 2026
Identifier
PAR-26-150
NAICS
541715
This opportunity from the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), seeks research proposals focused on early-onset cancers (EOCs) in adults aged 18 to 49. - Government Buyer: - National Institutes of Health (NIH) - National Cancer Institute (NCI) - Products/Services Requested: - Research projects investigating: - Etiology and biological mechanisms of sporadic, non-hereditary early-onset cancers - Early detection strategies and identification of at-risk populations - Modifiable exposures and host responses - Project types: - Exploratory/developmental (up to 2 years) - Full research projects (4 to 5 years) - OEMs and Vendors: - No specific OEMs or vendors are named, as this is a research grant opportunity - Unique or Notable Requirements: - Focus on non-hereditary cancers in young adults (18-49 years) - Research must address modifiable risk factors, biological mechanisms, or improved detection/identification - Broad eligibility: state/local/tribal governments, educational institutions, nonprofits, and for-profit businesses - No product or service procurement; funding is for research activities only
Description
The National Cancer Institute (NCI) invites applications to investigate the etiology of sporadic non-hereditary early-onset cancers (ages 18 to 49 years) and the biological mechanisms involved to inform prevention and control strategies. Research should focus on modifiable exposures driving the increase in incidence, underlying biological mechanisms and host responses, and improved identification of those at increased risk. The funding opportunity consolidates exploratory/developmental and research project mechanisms, allowing for project periods of up to 2 years or 4 to 5 years respectively. The goal is to advance understanding of the rise in cancers among young adults.